Skip to main content
NCBI home page
Molecular and Cellular Biology logoLink to Molecular and Cellular Biology
. 1997 May;17(5):2658–2668. doi: 10.1128/mcb.17.5.2658

Expression of the (recombinant) endogenous immunoglobulin heavy-chain locus requires the intronic matrix attachment regions.

A E Oancea 1, M Berru 1, M J Shulman 1
PMCID: PMC232116  PMID: 9111336

Abstract

The elements which regulate gene expression have traditionally been identified by their effects on reporter genes which have been transfected into cell lines or animals. It is generally assumed that these elements have a comparable role in expression of the corresponding endogenous locus. Nevertheless, several studies of immunoglobulin heavy-chain (IgH) gene expression have reported that the requirements for expressing IgH-derived transgenes differ from the requirements for expression of the endogenous IgH locus. Thus, although expression of transgenes requires multiple elements from the J(H)-C mu intron--the E mu core enhancer, the matrix attachment regions (MARs) which flank E mu, and several switch-associated elements--B-cell lines in which expression of the endogenous heavy-chain gene is maintained at the normal level in the absence of these intronic elements have occasionally been reported. Gene targeting offers an alternative method for assessing regulatory elements, one in which the role of defined segments of endogenous genes can be evaluated in situ. We have applied this approach to the IgH locus of a hybridoma cell line, generating recombinants which bear predetermined modifications in the functional, endogenous mu heavy-chain gene. Our analysis indicates the following. (i) Ninety-eight percent of the expression of the recombinant endogenous mu gene depends on elements in the MAR-E mu-MAR segment. (ii) Expression of the recombinant mu gene depends strongly on the MARs of the J(H)-C mu intron but not on the adjoining E mu core enhancer and switch regions; because our recombinant cell lines bear only a single copy of the mu gene, our results indicate that mu expression is activated by MAR elements lying within that same mu transcription unit. (iii) The MAR segment includes at least one activating element in addition to those defined previously by the binding of presumptive activating proteins in the nuclear matrix. (iv) Close association of the MARs with the E mu enhancer is not required for MAR-stimulated expression. (v) The other MARs in the IgH locus do not in their normal context provide the requisite MAR function.

Full Text

The Full Text of this article is available as a PDF (938.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aguilera R. J., Hope T. J., Sakano H. Characterization of immunoglobulin enhancer deletions in murine plasmacytomas. EMBO J. 1985 Dec 30;4(13B):3689–3693. doi: 10.1002/j.1460-2075.1985.tb04136.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Banerji J., Olson L., Schaffner W. A lymphocyte-specific cellular enhancer is located downstream of the joining region in immunoglobulin heavy chain genes. Cell. 1983 Jul;33(3):729–740. doi: 10.1016/0092-8674(83)90015-6. [DOI] [PubMed] [Google Scholar]
  3. Bautista D., Shulman M. J. A hit-and-run system for introducing mutations into the Ig H chain locus of hybridoma cells by homologous recombination. J Immunol. 1993 Aug 15;151(4):1950–1958. [PubMed] [Google Scholar]
  4. Boulikas T. Nature of DNA sequences at the attachment regions of genes to the nuclear matrix. J Cell Biochem. 1993 May;52(1):14–22. doi: 10.1002/jcb.240520104. [DOI] [PubMed] [Google Scholar]
  5. Buzina A., Shulman M. J. An element in the endogenous IgH locus stimulates gene targeting in hybridoma cells. Nucleic Acids Res. 1996 Apr 15;24(8):1525–1530. doi: 10.1093/nar/24.8.1525. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Chen J., Young F., Bottaro A., Stewart V., Smith R. K., Alt F. W. Mutations of the intronic IgH enhancer and its flanking sequences differentially affect accessibility of the JH locus. EMBO J. 1993 Dec;12(12):4635–4645. doi: 10.1002/j.1460-2075.1993.tb06152.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Cockerill P. N., Garrard W. T. Chromosomal loop anchorage of the kappa immunoglobulin gene occurs next to the enhancer in a region containing topoisomerase II sites. Cell. 1986 Jan 31;44(2):273–282. doi: 10.1016/0092-8674(86)90761-0. [DOI] [PubMed] [Google Scholar]
  8. Cockerill P. N. Nuclear matrix attachment occurs in several regions of the IgH locus. Nucleic Acids Res. 1990 May 11;18(9):2643–2648. doi: 10.1093/nar/18.9.2643. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Connor A., Collins C., Jiang L., McMaster M., Shulman M. J. Isolation of new nonsense and frameshift mutants in the immunoglobulin mu heavy-chain gene of hybridoma cells. Somat Cell Mol Genet. 1993 Jul;19(4):313–320. doi: 10.1007/BF01232744. [DOI] [PubMed] [Google Scholar]
  10. Dickinson L. A., Joh T., Kohwi Y., Kohwi-Shigematsu T. A tissue-specific MAR/SAR DNA-binding protein with unusual binding site recognition. Cell. 1992 Aug 21;70(4):631–645. doi: 10.1016/0092-8674(92)90432-c. [DOI] [PubMed] [Google Scholar]
  11. Fiering S., Epner E., Robinson K., Zhuang Y., Telling A., Hu M., Martin D. I., Enver T., Ley T. J., Groudine M. Targeted deletion of 5'HS2 of the murine beta-globin LCR reveals that it is not essential for proper regulation of the beta-globin locus. Genes Dev. 1995 Sep 15;9(18):2203–2213. doi: 10.1101/gad.9.18.2203. [DOI] [PubMed] [Google Scholar]
  12. Fiering S., Kim C. G., Epner E. M., Groudine M. An "in-out" strategy using gene targeting and FLP recombinase for the functional dissection of complex DNA regulatory elements: analysis of the beta-globin locus control region. Proc Natl Acad Sci U S A. 1993 Sep 15;90(18):8469–8473. doi: 10.1073/pnas.90.18.8469. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Forrester W. C., van Genderen C., Jenuwein T., Grosschedl R. Dependence of enhancer-mediated transcription of the immunoglobulin mu gene on nuclear matrix attachment regions. Science. 1994 Aug 26;265(5176):1221–1225. doi: 10.1126/science.8066460. [DOI] [PubMed] [Google Scholar]
  14. Gillies S. D., Morrison S. L., Oi V. T., Tonegawa S. A tissue-specific transcription enhancer element is located in the major intron of a rearranged immunoglobulin heavy chain gene. Cell. 1983 Jul;33(3):717–728. doi: 10.1016/0092-8674(83)90014-4. [DOI] [PubMed] [Google Scholar]
  15. Gram H., Zenke G., Geisse S., Kleuser B., Bürki K. High-level expression of a human immunoglobulin gamma 1 transgene depends on switch region sequences. Eur J Immunol. 1992 May;22(5):1185–1191. doi: 10.1002/eji.1830220512. [DOI] [PubMed] [Google Scholar]
  16. Gross-Bellard M., Oudet P., Chambon P. Isolation of high-molecular-weight DNA from mammalian cells. Eur J Biochem. 1973 Jul 2;36(1):32–38. doi: 10.1111/j.1432-1033.1973.tb02881.x. [DOI] [PubMed] [Google Scholar]
  17. Grosschedl R., Marx M. Stable propagation of the active transcriptional state of an immunoglobulin mu gene requires continuous enhancer function. Cell. 1988 Nov 18;55(4):645–654. doi: 10.1016/0092-8674(88)90223-1. [DOI] [PubMed] [Google Scholar]
  18. Herrscher R. F., Kaplan M. H., Lelsz D. L., Das C., Scheuermann R., Tucker P. W. The immunoglobulin heavy-chain matrix-associating regions are bound by Bright: a B cell-specific trans-activator that describes a new DNA-binding protein family. Genes Dev. 1995 Dec 15;9(24):3067–3082. doi: 10.1101/gad.9.24.3067. [DOI] [PubMed] [Google Scholar]
  19. Kadesch T., Zervos P., Ruezinsky D. Functional analysis of the murine IgH enhancer: evidence for negative control of cell-type specificity. Nucleic Acids Res. 1986 Oct 24;14(20):8209–8221. doi: 10.1093/nar/14.20.8209. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Kim C. G., Epner E. M., Forrester W. C., Groudine M. Inactivation of the human beta-globin gene by targeted insertion into the beta-globin locus control region. Genes Dev. 1992 Jun;6(6):928–938. doi: 10.1101/gad.6.6.928. [DOI] [PubMed] [Google Scholar]
  21. Klein S., Sablitzky F., Radbruch A. Deletion of the IgH enhancer does not reduce immunoglobulin heavy chain production of a hybridoma IgD class switch variant. EMBO J. 1984 Nov;3(11):2473–2476. doi: 10.1002/j.1460-2075.1984.tb02158.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Kowalski J., Denhardt D. T. Regulation of the mRNA for monocyte-derived neutrophil-activating peptide in differentiating HL60 promyelocytes. Mol Cell Biol. 1989 May;9(5):1946–1957. doi: 10.1128/mcb.9.5.1946. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Köhler G., Potash M. J., Lehrach H., Shulman M. J. Deletions in immunoglobulin mu chains. EMBO J. 1982;1(5):555–563. doi: 10.1002/j.1460-2075.1982.tb01208.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Laemmli U. K., Käs E., Poljak L., Adachi Y. Scaffold-associated regions: cis-acting determinants of chromatin structural loops and functional domains. Curr Opin Genet Dev. 1992 Apr;2(2):275–285. doi: 10.1016/s0959-437x(05)80285-0. [DOI] [PubMed] [Google Scholar]
  25. Lieberson R., Ong J., Shi X., Eckhardt L. A. Immunoglobulin gene transcription ceases upon deletion of a distant enhancer. EMBO J. 1995 Dec 15;14(24):6229–6238. doi: 10.1002/j.1460-2075.1995.tb00313.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Linial M., Gunderson N., Groudine M. Enhanced transcription of c-myc in bursal lymphoma cells requires continuous protein synthesis. Science. 1985 Dec 6;230(4730):1126–1132. doi: 10.1126/science.2999973. [DOI] [PubMed] [Google Scholar]
  27. Mulligan R. C., Berg P. Expression of a bacterial gene in mammalian cells. Science. 1980 Sep 19;209(4463):1422–1427. doi: 10.1126/science.6251549. [DOI] [PubMed] [Google Scholar]
  28. Neuberger M. S. Expression and regulation of immunoglobulin heavy chain gene transfected into lymphoid cells. EMBO J. 1983;2(8):1373–1378. doi: 10.1002/j.1460-2075.1983.tb01594.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Oancea A. E., Shulman M. J. An improved system of somatic cell molecular genetics for analyzing the requirements of Ig synthesis and function. Int Immunol. 1994 Aug;6(8):1161–1168. doi: 10.1093/intimm/6.8.1161. [DOI] [PubMed] [Google Scholar]
  30. Oancea A. E., Tsui F. W., Shulman M. J. Targeted removal of the mu switch region from mouse hybridoma cells. A test of its role in gene expression in the endogenous IgH locus. J Immunol. 1995 Dec 15;155(12):5678–5683. [PubMed] [Google Scholar]
  31. Olson E. N., Arnold H. H., Rigby P. W., Wold B. J. Know your neighbors: three phenotypes in null mutants of the myogenic bHLH gene MRF4. Cell. 1996 Apr 5;85(1):1–4. doi: 10.1016/s0092-8674(00)81073-9. [DOI] [PubMed] [Google Scholar]
  32. Pham C. T., MacIvor D. M., Hug B. A., Heusel J. W., Ley T. J. Long-range disruption of gene expression by a selectable marker cassette. Proc Natl Acad Sci U S A. 1996 Nov 12;93(23):13090–13095. doi: 10.1073/pnas.93.23.13090. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Pommier Y., Cockerill P. N., Kohn K. W., Garrard W. T. Identification within the simian virus 40 genome of a chromosomal loop attachment site that contains topoisomerase II cleavage sites. J Virol. 1990 Jan;64(1):419–423. doi: 10.1128/jvi.64.1.419-423.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Porton B., Zaller D. M., Lieberson R., Eckhardt L. A. Immunoglobulin heavy-chain enhancer is required to maintain transfected gamma 2A gene expression in a pre-B-cell line. Mol Cell Biol. 1990 Mar;10(3):1076–1083. doi: 10.1128/mcb.10.3.1076. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Scheuermann R. H., Chen U. A developmental-specific factor binds to suppressor sites flanking the immunoglobulin heavy-chain enhancer. Genes Dev. 1989 Aug;3(8):1255–1266. doi: 10.1101/gad.3.8.1255. [DOI] [PubMed] [Google Scholar]
  36. Shulman M. J., Heusser C., Filkin C., Köhler G. Mutations affecting the structure and function of immunoglobulin M. Mol Cell Biol. 1982 Sep;2(9):1033–1043. doi: 10.1128/mcb.2.9.1033. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Shulman M. J., Nissen L., Collins C. Homologous recombination in hybridoma cells: dependence on time and fragment length. Mol Cell Biol. 1990 Sep;10(9):4466–4472. doi: 10.1128/mcb.10.9.4466. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Sigurdardottir D., Sohn J., Kass J., Selsing E. Regulatory regions 3' of the immunoglobulin heavy chain intronic enhancer differentially affect expression of a heavy chain transgene in resting and activated B cells. J Immunol. 1995 Mar 1;154(5):2217–2225. [PubMed] [Google Scholar]
  39. Su L. K., Kadesch T. The immunoglobulin heavy-chain enhancer functions as the promoter for I mu sterile transcription. Mol Cell Biol. 1990 Jun;10(6):2619–2624. doi: 10.1128/mcb.10.6.2619. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Sun W., Xiong J., Shulman M. J. Production of mouse V/human C chimeric kappa genes by homologous recombination in hybridoma cells. Analysis of vector design and recombinant gene expression. J Immunol. 1994 Jan 15;152(2):695–704. [PubMed] [Google Scholar]
  41. Wabl M. R., Burrows P. D. Expression of immunoglobulin heavy chain at a high level in the absence of a proposed immunoglobulin enhancer element in cis. Proc Natl Acad Sci U S A. 1984 Apr;81(8):2452–2455. doi: 10.1073/pnas.81.8.2452. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Wasylyk C., Wasylyk B. The immunoglobulin heavy-chain B-lymphocyte enhancer efficiently stimulates transcription in non-lymphoid cells. EMBO J. 1986 Mar;5(3):553–560. doi: 10.1002/j.1460-2075.1986.tb04246.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Zaller D. M., Eckhardt L. A. Deletion of a B-cell-specific enhancer affects transfected, but not endogenous, immunoglobulin heavy-chain gene expression. Proc Natl Acad Sci U S A. 1985 Aug;82(15):5088–5092. doi: 10.1073/pnas.82.15.5088. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Zong R. T., Scheuermann R. H. Mutually exclusive interaction of a novel matrix attachment region binding protein and the NF-muNR enhancer repressor. Implications for regulation of immunoglobulin heavy chain expression. J Biol Chem. 1995 Oct 13;270(41):24010–24018. doi: 10.1074/jbc.270.41.24010. [DOI] [PubMed] [Google Scholar]

Articles from Molecular and Cellular Biology are provided here courtesy of Taylor & Francis

RESOURCES